This is of particular interest in the context of metabolic disease, since altered leptin profiles (such as leptin resistance, insufficient or dysfunctional leptin production or signalling) accompanying obesity may interact with the HPA axis in order to contribute to metabolic disorder. The gene discussed is LEP; the disease is Obesity.